Baltimore, MD, United States of America

HeungBae Jeon

This inventor holds 1 USPTO granted patent. Top assignees: Cytochroma Inc., Johns Hopkins University. Active years: 2007.


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: HeungBae Jeon: Innovator in Vitamin D Research

Introduction

HeungBae Jeon is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of vitamin D research, particularly through his innovative patent work. His expertise and dedication to advancing medical science have positioned him as a key figure in his area of specialization.

Latest Patents

HeungBae Jeon holds 1 patent related to novel C24-sulfone analogs of 1α,25-dihydroxy vitamin D. This patent provides compositions comprising these compounds and methods for using them as selective inhibitors of CYP24. The compounds developed by Jeon are particularly useful for treating diseases that benefit from modulation of the levels of 1α,25-dihydroxy vitamin D, such as cell-proliferative disorders.

Career Highlights

Throughout his career, HeungBae Jeon has worked with prominent organizations, including Cytochroma Inc. and Johns Hopkins University. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

HeungBae Jeon has collaborated with notable colleagues, including Gary H Posner and Kenneth R Crawford. These partnerships have further enhanced his research and innovation in the field of vitamin D.

Conclusion

HeungBae Jeon is a distinguished inventor whose work has significantly impacted vitamin D research. His innovative patents and collaborations with esteemed institutions and colleagues highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…